Skip Nav Destination
Issues
1 June 2020
-
Cover Image
Cover Image
The FGF system plays a pivotal role in multiple myeloma growth and dissemination. FGF antagonists promote mitochondrial oxidative stress and apoptosis in myeloma cells by inducing proteasomal degradation of the c-Myc oncoprotein. Inhibition of the FGF system prevents the homing of grafted human myeloma cells to the bone marrow-like caudal niche of zebrafish embryos. This study provides new insights into the mechanisms by which FGF antagonists promote multiple myeloma cell death. For details, see article by Ronca and colleagues on page 2340. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Insights
Review
Cancer Research Highlights
Priority Reports
Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma
Kazutoshi Yamamoto; Jeffrey R. Brender; Tomohiro Seki; Shun Kishimoto; Nobu Oshima; Rajani Choudhuri; Stephen S. Adler; Elaine M. Jagoda; Keita Saito; Nallathamby Devasahayam; Peter L. Choyke; James B. Mitchell; Murali C. Krishna
Author Choice
ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer
Shahrzad Rafiei; Kenyon Fitzpatrick; David Liu; Mu-Yan Cai; Haitham A. Elmarakeby; Jihye Park; Cora Ricker; Bose S. Kochupurakkal; Atish D. Choudhury; William C. Hahn; Steven P. Balk; Justin H. Hwang; Eliezer M. Van Allen; Kent W. Mouw
Genome and Epigenome
Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants
Sam C. Wang; Yunku Yeu; Suntrea T.G. Hammer; Shu Xiao; Min Zhu; Changjin Hong; Jean R. Clemenceau; Lynn Y. Yoon; Ibrahim Nassour; Jeanne Shen; Deepak Agarwal; Scott I. Reznik; John C. Mansour; Adam C. Yopp; Hao Zhu; Tae Hyun Hwang; Matthew R. Porembka
Metabolism and Chemical Biology
Author Choice
GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
Jianjiang Xie; Jianheng Ye; Zhiduan Cai; Yong Luo; Xuejin Zhu; Yulin Deng; Yuanfa Feng; Yingke Liang; Ren Liu; Zhaodong Han; Yuxiang Liang; Yu Zheng; Rujun Mo; Yangjia Zhuo; Yongding Wu; Funeng Jiang; Jianguo Zhu; Chin-Lee Wu; Weide Zhong
Molecular Cell Biology
Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53
Yunzhao Chen; Huahua Xin; Hao Peng; Qi Shi; Menglu Li; Jie Yu; Yanxia Tian; Xueping Han; Xi Chen; Yi Zheng; Jun Li; Zhihao Yang; Lan Yang; Jianming Hu; Xuan Huang; Zheng Liu; Xiaoxi Huang; Hong Zhou; Xiaobin Cui; Feng Li
Rapalog-Mediated Repression of Tribbles Pseudokinase 3 Regulates Pre-mRNA Splicing
Bojana Stefanovska; Cecile Edith Vicier; Thibault Dayris; Vasily Ogryzko; Veronique Scott; Ibrahim Bouakka; Suzette Delaloge; Anna Rocca; Olivia Le Saux; Olivier Trédan; Thomas Bachelot; Fabrice André; Olivia Fromigué
Tumor Biology and Immunology
The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression
Jaebeom Cho; Hyo-Jong Lee; Su Jung Hwang; Hye-Young Min; Han Na Kang; A-Young Park; Seung Yeob Hyun; Jeong Yeon Sim; Ho Jin Lee; Hyun-Ji Jang; Young-Ah Suh; Sungyoul Hong; Young Kee Shin; Hye Ryun Kim; Ho-Young Lee
Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity
Linlin Sun; Chia-Wei Li; Ezra M. Chung; Riyao Yang; Yong-Soo Kim; Andrew H. Park; Yun-Ju Lai; Yi Yang; Yu-Han Wang; Jielin Liu; Yufan Qiu; Kay-Hooi Khoo; Jun Yao; Jennifer L. Hsu; Jong-Ho Cha; Li-Chuan Chan; Jung-Mao Hsu; Heng-Huan Lee; Stephen S. Yoo; Mien-Chie Hung
Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype
Maria Teresa Majorini; Valeria Cancila; Alice Rigoni; Laura Botti; Matteo Dugo; Tiziana Triulzi; Loris De Cecco; Enrico Fontanella; Elena Jachetti; Elda Tagliabue; Claudia Chiodoni; Claudio Tripodo; Mario P. Colombo; Daniele Lecis
Author Choice
RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
Nicholas Rooney; Susan M. Mason; Laura McDonald; J. Henry M. Däbritz; Kirsteen J. Campbell; Ann Hedley; Steven Howard; Dimitris Athineos; Colin Nixon; William Clark; Joshua D.G. Leach; Owen J. Sansom; Joanne Edwards; Ewan R. Cameron; Karen Blyth
Translational Science
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
Roberto Ronca; Gaia C. Ghedini; Federica Maccarinelli; Antonio Sacco; Silvia L. Locatelli; Eleonora Foglio; Sara Taranto; Elisabetta Grillo; Sara Matarazzo; Riccardo Castelli; Giuseppe Paganini; Vanessa Desantis; Nadia Cattane; Annamaria Cattaneo; Marco Mor; Carmelo Carlo-Stella; Angelo Belotti; Aldo M. Roccaro; Marco Presta; Arianna Giacomini
Author Choice
IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment
Jonathan M. Harnoss; Adrien Le Thomas; Mike Reichelt; Ofer Guttman; Thomas D. Wu; Scot A. Marsters; Anna Shemorry; David A. Lawrence; David Kan; Ehud Segal; Mark Merchant; Klara Totpal; Lisa M. Crocker; Kathryn Mesh; Monika Dohse; Margaret Solon; Zora Modrusan; Joachim Rudolph; Hartmut Koeppen; Peter Walter; Avi Ashkenazi
Convergence and Technologies
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML
Tom Hähnel; Christoph Baldow; Joëlle Guilhot; François Guilhot; Susanne Saussele; Satu Mustjoki; Stefanie Jilg; Philipp J. Jost; Stephanie Dulucq; François-Xavier Mahon; Ingo Roeder; Artur C. Fassoni; Ingmar Glauche
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.